Inhibition of the Sur1-Trpm4 Channel Reduces Neuroinflammation and Cognitive Impairment in Subarachnoid Hemorrhage
Author(s) -
Çiğdem Tosun,
David B. Kurland,
Rupal I. Mehta,
Rudy J. Castellani,
Joyce L. deJong,
Min Seong Kwon,
Seung Kyoon Woo,
Volodymyr Gerzanich,
J. Marc Simard
Publication year - 2013
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.113.002904
Subject(s) - neuroinflammation , medicine , glibenclamide , extravasation , entorhinal cortex , subarachnoid hemorrhage , downregulation and upregulation , neuroscience , anesthesia , pharmacology , pathology , endocrinology , inflammation , hippocampus , chemistry , biology , biochemistry , gene , diabetes mellitus
Subarachnoid hemorrhage (SAH) can leave patients with memory impairments that may not recover fully. Molecular mechanisms are poorly understood, and no treatment is available. The sulfonylurea receptor 1-transient receptor potential melastatin 4 (Sur1-Trpm4) channel plays an important role in acute central nervous system injury. We evaluated upregulation of Sur1-Trpm4 in humans with SAH and, in rat models of SAH, we examined Sur1-Trpm4 upregulation, its role in barrier dysfunction and neuroinflammation, and its consequences on spatial learning.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom